Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GENPHARMASEC LTD.

NSE : NABSE : 531592ISIN CODE : INE861N01036Industry : Dyes & PigmentsHouse : Private

BSE2.060 (0 %)

PREV CLOSE ( ) 2.06

OPEN PRICE ( ) 2.04

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 295918

TODAY'S LOW / HIGH ( )2.04 2.08

52 WK LOW / HIGH ( ) 1.894.32

NSE

This Company is not listed in NSE

Company Secretary	Hardik Makwana
Non Executive Independent Director	Siddhesh Shende Mayur Bhatt Sachin Aphandkar
Whole Time Director	Sohan Chaturvedi
Non Independent & Non Executive Director	Sneha Sadhwani Rajesh Sadhwani

Incorporation Year : 16-11 1992

Registered Office :

Address : Office No.104 & 105 (1st Floor),Gundecha Industrial Premises Co-operative Society Ltd,Akurli Road, Kandivali (East) Mumbai,
Maharashtra-400101 .

Phone : 8655550242

Email : info@genpharmasec.com / compliance@genpharmasec.com

URL : www.genpharmasec.com

Industry : Dyes & Pigments

Listing : BSE

Risk Disclosures on Derivatives

Company Information

GENPHARMASEC LTD.